Glenn Greenberg
Brave Warrior Advisors
Brave Warrior Advisors Portfolio 13F
Glenn Greenberg Holdings Activity
- Portfolio value:
- $1.87B≈ (-$6M≈)
- Previous value:
- $1.88B≈
- # of changes:
- 17
- New positions:
- 1
- Reported for:
- 30 Sep 2019 (Q3)
- Latest filing date:
- 14 Nov 2019
Brave Warrior Advisors has disclosed a total of 17 changes to the portfolio in the (2019 Q3) SEC report(s): increased the number of shares of 4, bought 1 totally new, decreased the number of shares of 9 and completely sold out 3 position(s).
What stocks did Glenn Greenberg buy in 2019 Q3?
During 2019 Q3 Glenn Greenberg has purchased 5 securities: (BRK-B) Berkshire Hathaway Inc (added shares +19.41%), (RJF) Raymond James Financial Inc (added shares +5.86%), (ELV) Elevance Health Inc (new buy), (PRI) Primerica Inc (added shares +15.81%) and (BAC) Bank of America Corp (added shares +0.10%).
What did Glenn Greenberg invest in during 2019 Q3?
In the 2019 Q3 report(s) the following changes have been made to the top investments: (GOOGL) Alphabet Inc, CL-A (reduced shares -0.72%), (BRK-B) Berkshire Hathaway Inc (added shares +19.41%), (JPM) JPMorgan Chase & Co (reduced shares -0.60%), (RJF) Raymond James Financial Inc (added shares +5.86%) and (ELV) Elevance Health Inc (new buy).
17 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Elevance Health Inc
|
new
|
$240.10
|
+57.47%($378.08)
|
8.18%
|
2019 Q3
|
≈ 0.25 years
|
||||
|
|
Berkshire Hathaway Inc
|
+19.41%
|
$208.02
|
+137.62%($494.30)
|
16.69%
|
2019 Q2
|
≈ 0.50 years
|
||||
|
|
Primerica Inc
|
+15.81%
|
$127.23
|
+147.88%($315.38)
|
5.96%
|
2013 Q2 or earlier
|
≈ 6.50+ years
|
||||
|
|
Raymond James Financial Inc
|
+5.86%
|
$123.69
|
+39.94%($173.09)
|
11.33%
|
2018 Q3
|
≈ 1.25 years
|
||||
|
|
Bank of America Corp
|
+0.10%
|
$29.15
|
+112.99%($62.08)
|
0.02%
|
2013 Q4
|
≈ 6.00 years
|
||||
|
|
DR Horton Inc
|
-0.39%
|
$52.71
|
+179.40%($147.27)
|
3.55%
|
2018 Q3
|
≈ 1.25 years
|
||||
|
|
JPMorgan Chase & Co
|
-0.60%
|
$117.69
|
+200.60%($353.78)
|
12.73%
|
2014 Q3
|
≈ 5.25 years
|
||||
|
|
Alphabet Inc, CL-A
|
-0.72%
|
$61.06
|
+434.86%($326.57)
|
19.14%
|
2017 Q4
|
≈ 2.00 years
|
||||
|
|
Charles Schwab Corp
|
-0.73%
|
$41.83
|
+148.60%($103.99)
|
7.54%
|
2013 Q2 or earlier
|
≈ 6.50+ years
|
||||
|
|
Citigroup Inc
|
-1.12%
|
$69.08
|
+90.46%($131.57)
|
5.06%
|
2018 Q3
|
≈ 1.25 years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.